In 2012, the United States experienced one of the worst pharmaceutical contamination disasters in its history. The New England Compounding Center, a drug compounding facility in Massachusetts, shipped thousands of vials of methylprednisolone acetate, a steroid injection commonly used for back pain, to clinics across the country. The medicine was contaminated with a fungus called Exserohilum rostratum. Over 750 patients were infected with fungal meningitis, a severe and often fatal infection of the spinal cord and brain. More than 60 people died. This outbreak is a textbook example of how product liability law applies when contaminated medicine reaches consumers.

The legal principle at the heart of this case is strict liability. Under this rule, a manufacturer or supplier of a product is legally responsible for injuries caused by a defective product, regardless of how careful the company was in making it. You do not need to prove that the company was negligent or intended to harm anyone. You only need to show that the product was defective and that the defect caused your injury. In the NECC outbreak, the steroid vials were clearly defective because they contained a deadly fungus that should never have been present in sterile injectable medicine. The fact that NECC may have followed some safety protocols does not matter. Strict liability puts the burden on the manufacturer, not the patient, to absorb the cost of defective products.

There is also a second legal theory available to victims: negligence. Negligence requires showing that the company failed to use reasonable care, which is a higher bar than strict liability. In the NECC case, the evidence painted a damning picture of systemic carelessness. Investigators found that the company had not properly sterilized its equipment, had not maintained clean rooms to required standards, and had shipped products before receiving test results confirming sterility. Those failures amount to negligence. Victims could also bring a breach of warranty claim, arguing that NECC implicitly promised the medicine was safe for use and that promise was broken.

One critical legal issue in the NECC case was the question of who is liable. NECC was a compounding pharmacy, not a traditional pharmaceutical manufacturer like Pfizer or Merck. Compounding pharmacies are regulated differently, often by state boards of pharmacy rather than the FDA, and they operate under looser oversight. However, courts have consistently ruled that compounders are still “manufacturers” for product liability purposes. When NECC mixed, filled, and shipped the steroid, it became the producing party and was held to the same strict liability standards.

Another layer of liability involved the clinics that ordered and administered the injections. Could a doctor or hospital be sued for using a contaminated product? Generally, healthcare providers are not considered sellers or distributors of the medicine itself. They are the end users. But they can be sued for medical malpractice if they ignored warning signs or failed to diagnose the infection promptly. In the NECC outbreak, many clinics settled with victims for not flagging the unusual number of infections sooner.

The victims in this outbreak faced devastating consequences. Spinal and brain infections with Exserohilum require months of intravenous antifungal therapy, often with serious side effects like kidney damage and vision loss. Many survivors are left with chronic pain, paralysis, or cognitive impairment. In product liability law, damages for these injuries cover medical expenses, lost income, pain and suffering, and in death cases, funeral costs and loss of financial support for dependents.

The NECC case also highlighted an important practical point: proving causation. Victims had to show that the specific batch of steroid they received contained the fungus. The Centers for Disease Control and Prevention tracked lot numbers and confirmed contamination through lab testing. This kind of evidence is essential in product liability cases, especially when a product is used by many people and only some fall ill.

After the outbreak, NECC filed for bankruptcy. The company’s owners and pharmacists faced criminal charges, which is separate from civil product liability. While criminal law punishes intentional wrongdoing, product liability focuses on compensating victims. Many victims fought for years to recover money from the bankruptcy estate and from insurance policies. The payout was limited, and many families never received full compensation for their losses.

This case is a stark reminder that product liability is not about punishing companies for being bad. It is about protecting ordinary people from unsafe products. When a manufacturer puts a contaminated drug into the market, the legal system allows victims to demand accountability. They do not need to prove negligence if strict liability applies. They do not need to understand pharmaceutical chemistry. They only need to show that the product was defective and it hurt them. That is the core purpose of product liability law: a no-nonsense, no-legalese system that shifts the risk of dangerous products from the injured person to the party who created the danger.